Correlation Between Meli Hotels and Lion Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Meli Hotels and Lion Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Meli Hotels and Lion Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Meli Hotels International and Lion Biotechnologies, you can compare the effects of market volatilities on Meli Hotels and Lion Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Meli Hotels with a short position of Lion Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Meli Hotels and Lion Biotechnologies.

Diversification Opportunities for Meli Hotels and Lion Biotechnologies

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Meli and Lion is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Meli Hotels International and Lion Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lion Biotechnologies and Meli Hotels is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Meli Hotels International are associated (or correlated) with Lion Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lion Biotechnologies has no effect on the direction of Meli Hotels i.e., Meli Hotels and Lion Biotechnologies go up and down completely randomly.

Pair Corralation between Meli Hotels and Lion Biotechnologies

Assuming the 90 days horizon Meli Hotels International is expected to generate 0.57 times more return on investment than Lion Biotechnologies. However, Meli Hotels International is 1.76 times less risky than Lion Biotechnologies. It trades about 0.14 of its potential returns per unit of risk. Lion Biotechnologies is currently generating about -0.21 per unit of risk. If you would invest  688.00  in Meli Hotels International on September 23, 2024 and sell it today you would earn a total of  38.00  from holding Meli Hotels International or generate 5.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Meli Hotels International  vs.  Lion Biotechnologies

 Performance 
       Timeline  
Meli Hotels International 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Meli Hotels International are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Meli Hotels may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Lion Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lion Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Meli Hotels and Lion Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Meli Hotels and Lion Biotechnologies

The main advantage of trading using opposite Meli Hotels and Lion Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Meli Hotels position performs unexpectedly, Lion Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lion Biotechnologies will offset losses from the drop in Lion Biotechnologies' long position.
The idea behind Meli Hotels International and Lion Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance